Andere Sprachen Bukwang Pharmaceutical Co., Ltd.

Aktien

A003000

KR7003000007

A003000

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 20.05.2024			% 5 Tage	% 1. Jan.
6 530 ^KRW	-0,31 %		-1,06 %	+7,05 %

01.04.	H Delta Private Equity Partnership hat die Übernahme von 24,4% der Anteile an Contera Pharma ApS von Bukwang Pharmaceutical Co., Ltd. für 6,3 Milliarden KRW abgeschlossen.	CI
26.03.	Bukwang Pharmaceutical-Aktien steigen nach Ankündigung des Rückkaufprogramms stark an	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

H Delta Private Equity Partnership completed the acquisition of 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion.	01.04.
Bukwang Pharmaceutical Shares Surge Following Buyback Program Announcement	26.03.
H Delta Private Equity Partnership agreed to acquire 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion.	22.03.
Bukwang Pharmaceutical : IR Fact Book 4Q23 (Reviewed by External Auditor)	15.03.
Bukwang Pharmaceutical : IR presentation 4Q23 (Reviewed by External Auditor)	15.03.
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10.08.23
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15.05.23
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11.11.22
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16.08.22
Bukwang Pharmaceutical Co., Ltd.(KOSE:A003000) dropped from KOSPI 200 Index	09.06.22
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	13.05.22
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17.03.22
OCI Company Ltd. completed the acquisition of additional 10.878134% stake in Bukwang Pharmaceutical Co., Ltd. (KOSE : A003000) from Kim Sanghun and 8 other shareholders for approximately KRW 150 billion.	03.03.22
OCI Company Ltd. agreed to acquire an additional 10.878134% stake in Bukwang Pharmaceutical Co., Ltd. (KOSE : A003000) from Kim Sanghun and 8 other shareholders for approximately KRW 150 billion.	22.02.22
ImmPACT Bio USA Inc. announced that it has received $110.855843 million in funding from a group of investors	20.01.22
ImmPACT Bio USA Inc. announced that it expects to receive $110.855843 million in funding	14.01.22
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12.11.21
Bukwang Pharmaceutical : confirmed Levovir showed tendency of reducing virus from Phase 2 clinical trial topline data	13.05.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bukwang Pharmaceutical Co., Ltd.

Aktien

A003000

KR7003000007

A003000

Andere Sprachen

Filter